Neurokappa Therapeutics LLC

Website
3401 Grays Ferry Ave Ste 212-129
Philadelphia, PA 19146
https://neurokor.com

Neurokappa Therapeutics LLC is a Philadelphia-based company comprised of a team of scientists and business professionals dedicated to developing innovative medications for neurological diseases such as stroke, pain, and addiction. Leveraging their deep understanding of opioid receptors, they aim to create novel compounds that target these receptors, with potential therapeutic applications in stroke therapy, pain management, depression, and addiction therapy.

The company's vision is to provide an effective alternative pathway for delivering medications for neurological diseases, particularly in out-of-hospital settings where intravenous access may not be readily available. With a focus on prioritizing the efficacy of action over the mechanism of actions, Neurokappa Therapeutics LLC is committed to continuously pursuing both scientific discoveries and the development of new indications for existing medications.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Biological research

Carisma Therapeutics Inc

Carisma Therapeutics Inc. is a Philadelphia-based biotech company that is revolutionizing cancer treatment through the development of CAR-Macrophages, a groundbreaking approach to immunotherapy. By engineering monocytes and macrophages to attack tumors, Carisma's innovative cellular therapies have the potential to deliver long-term anti-tumor immunity and significantly improve patient outcomes. With a focus on leveraging advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy, Carisma's unique therapeutic approach engages both the innate and adaptive immune systems to launch a multi-pronged attack on tumors. By addressing key challenges faced by current cell therapies, such as tumor infiltration, immunosuppressive tumor microenvironments, and antigen heterogeneity, Carisma is at the forefront of developing life-changing treatments for patients with cancer and other serious disorders.Generated from the website
Drugs and drug proprietaries

Ayala Pharmaceuticals, Inc

Ayala Pharmaceuticals, Inc, based in Monmouth Junction, NJ, is a biopharmaceutical company focused on developing innovative therapies. In the first quarter of 2024, the company announced the acquisition of AL102 and AL101 by Immunome Inc. Additionally, Ayala Pharmaceuticals is involved with other products such as BST-236. The company's leadership and research efforts are oriented towards advancing treatment options in the medical field. Generated from the website
Drugs and drug proprietaries, Vitamin, nutrient, and hematinic preparations for human use

Inovio Pharmaceuticals, Inc

INOVIO Pharmaceuticals, Inc, located in Plymouth Meeting, is at the forefront of developing innovative immunotherapy technologies. Their focus is on revolutionizing the treatment and prevention of infectious diseases and cancer, paving the way for a new era in healthcare. Generated from their website's infomation
United States›Pennsylvania›Philadelphia›Neurokappa Therapeutics LLC

Partial Data by Infogroup (c) 2025. All rights reserved.